Exactech (EXAC) Q1 Preliminary Results Miss Views

Exactech, Inc.(Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, said today the company’s financial results for the first quarter ended March 31, 2015 will be slightly below the company’s previously announced guidance. The company attributed the shortfall to foreign currency pressure and softer than expected sales.

The company expects revenues for the quarter to be $61.4 million and diluted earnings per share for the quarter to be in the range of $0.29 - $0.30.

(Street sees Q1 EPS of $0.30 on revenue of $63.71)

The company will release its first quarter 2015 financial results after the market closes on Tuesday, April 28th, 2015.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• L3Harris Technologies (LHX) Tops Q1 EPS by 15c; raises guidance
• Macatawa Bank (MCBC) Misses Q1 EPS by 1c